Works by Inal, Ahmet


Results: 13
    1
    2
    3
    4
    5
    6

    Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up.

    Published in:
    Vaccines, 2024, v. 12, n. 2, p. 140, doi. 10.3390/vaccines12020140
    By:
    • Sezer, Zafer;
    • Pavel, Shaikh Terkis Islam;
    • Inal, Ahmet;
    • Yetiskin, Hazel;
    • Kaplan, Busra;
    • Uygut, Muhammet Ali;
    • Aslan, Ahmet Furkan;
    • Bayram, Adnan;
    • Mazicioglu, Mumtaz;
    • Kalin Unuvar, Gamze;
    • Yuce, Zeynep Ture;
    • Aydin, Gunsu;
    • Kaya, Refika Kamuran;
    • Ates, Ihsan;
    • Kara, Ates;
    • Ozdarendeli, Aykut
    Publication type:
    Article
    7
    8

    YAPAY ZEKÂ BAĞLAMINDA ETİK PROBLEMİ.

    Published in:
    Journal of International Social Research, 2019, v. 12, n. 66, p. 651, doi. 10.17719/jisr.2019.3614
    By:
    • ÇELEBİ, Vedat;
    • İNAL, Ahmet
    Publication type:
    Article
    9
    10

    Vaccination with inactivated SARS-CoV-2 vaccine TURKOVAC induces durable humoral and cellular immune responses up to 8 months.

    Published in:
    Frontiers in Medicine, 2025, p. 1, doi. 10.3389/fmed.2025.1524393
    By:
    • Yılmaz, Seçil;
    • Eken, Ahmet;
    • Sezer, Zafer;
    • Bağcı, Burcu Şen;
    • Erdem, Serife;
    • Sarıkaya, Medine Doğan;
    • Kaplan, Busra;
    • Inal, Ahmet;
    • Bayram, Adnan;
    • Kalın Unuvar, Gamze;
    • Zararsız, Gokmen;
    • Yerlitas, Serra İlayda;
    • Cakir, Nuri;
    • Pavel, Shaikh Terkis Islam;
    • Uygut, Muhammet Ali;
    • Yetiskin, Hazel;
    • Kara, Ates;
    • Ozdarendeli, Aykut
    Publication type:
    Article
    11
    12
    13